Development of Sirna Nanojackets for Influenza Treatment

Period of Performance: 08/01/2015 - 07/31/2016

$225K

Phase 1 SBIR

Recipient Firm

Keystone Nano, Inc.
State College, PA 16801
Principal Investigator

Abstract

To develop broad spectrum anti-influenza treatments.